Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.218NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.12.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.22 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.123 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.71NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21359South Korea
BA.2.12.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.51NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XRNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.350.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.86NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.154NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
A.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.137NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.446NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.76 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.398NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.163NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.3 (Theta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.38.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAVNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.4.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.77NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BY.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.97NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.59NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
B.1.177.67NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.277NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
AY.28 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.272NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.371NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AA.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.425NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
B.1.1.144NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used